During the past decade, Department of infectious disease, First Hospital of Peking University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of infectious disease, First Hospital of Peking University" #1 collaborator was "Major Science and Technology Special Project of China Eleventh Five-year" with 4 trials as a collaborator, "Novartis" with 3 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "JiangSu Chia-Tai Tianqin Pharmacy Co.Ltd" with 1 trials as a collaborator and "Major Science and Technology Special Project of China 12th Five-year" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Department of infectious disease, First Hospital of Peking University" are "Chronic Hepatitis B" (3 trials), "Hepatitis B, Chronic" (3 trials), "Compensated Chronic Hepatitis B" (1 trials), "Hepatitis B" (1 trials) and "Inadequate Response" (1 trials). Many other conditions were trialed in "Department of infectious disease, First Hospital of Peking University" in a lesser frequency.

Most popular intervention types in "Department of infectious disease, First Hospital of Peking University" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Entecavir, Adefovir" (2 trials), "Adefovir dipivoxil" (1 trials), "Entecavir" (1 trials), "Telbivudine" (1 trials) and "Telbivudine (Standard of Care)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of infectious disease, First Hospital of Peking University" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Department of infectious disease, First Hospital of Peking University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department of infectious disease, First Hospital of Peking University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of infectious disease, First Hospital of Peking University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 0 trials that are defined as “Not Applicable".